GBP3.56
2.47% yesterday
London, Apr 01, 05:44 pm CET
ISIN
GB00B082RF11
Symbol
RTO
Sector
Industry

Rentokil Initial Target price 2025 - Analyst rating & recommendation

Rentokil Initial Classifications & Recommendation:

Buy
42%
Hold
58%

Rentokil Initial Price Target

Target Price GBP4.29
Price GBP3.56
Potential
Number of Estimates 17
17 Analysts have issued a price target Rentokil Initial 2026 . The average Rentokil Initial target price is GBP4.29. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 19 analysts: 8 Analysts recommend Rentokil Initial to buy, 11 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Rentokil Initial stock has an average upside potential 2026 of . Most analysts recommend the Rentokil Initial stock at Hold.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion GBP 5.44 5.58
1.13% 2.60%
EBITDA Margin 21.47% 21.16%
15.03% 1.43%
Net Margin 5.55% 6.36%
20.90% 14.64%

16 Analysts have issued a sales forecast Rentokil Initial 2025 . The average Rentokil Initial sales estimate is

GBP5.6b
Unlock
. This is
2.60% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
GBP5.7b 4.36%
Unlock
, the lowest is
GBP5.5b 1.02%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 GBP5.4b 1.13%
2025
GBP5.6b 2.60%
Unlock
2026
GBP5.8b 3.27%
Unlock
2027
GBP6.0b 4.09%
Unlock
2028
GBP6.5b 8.81%
Unlock

16 Analysts have issued an Rentokil Initial EBITDA forecast 2025. The average Rentokil Initial EBITDA estimate is

GBP1.2b
Unlock
. This is
9.81% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
GBP1.3b 18.31%
Unlock
, the lowest is
GBP1.1b 0.24%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 GBP1.2b 14.06%
2025
GBP1.2b 1.15%
Unlock
2026
GBP1.2b 5.41%
Unlock
2027
GBP1.3b 6.43%
Unlock
2028
GBP1.4b 8.67%
Unlock

EBITDA Margin

2024 21.47% 15.03%
2025
21.16% 1.43%
Unlock
2026
21.60% 2.08%
Unlock
2027
22.09% 2.27%
Unlock
2028
22.06% 0.14%
Unlock

9 Rentokil Initial Analysts have issued a net profit forecast 2025. The average Rentokil Initial net profit estimate is

GBP355m
Unlock
. This is
17.64% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
GBP394m 30.57%
Unlock
, the lowest is
GBP269m 10.83%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 GBP302m 20.00%
2025
GBP355m 17.64%
Unlock
2026
GBP426m 20.03%
Unlock
2027
GBP482m 13.13%
Unlock

Net Margin

2024 5.55% 20.90%
2025
6.36% 14.64%
Unlock
2026
7.39% 16.19%
Unlock
2027
8.03% 8.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share GBP 0.12 0.14
20.00% 16.67%
P/E 25.23
EV/Sales 2.17

9 Analysts have issued a Rentokil Initial forecast for earnings per share. The average Rentokil Initial EPS is

GBP0.14
Unlock
. This is
16.67% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
GBP0.16 33.33%
Unlock
, the lowest is
GBP0.11 8.33%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 GBP0.12 20.00%
2025
GBP0.14 16.67%
Unlock
2026
GBP0.17 21.43%
Unlock
2027
GBP0.19 11.76%
Unlock

P/E ratio

Current 29.22 6.23%
2025
25.23 13.66%
Unlock
2026
21.02 16.69%
Unlock
2027
18.58 11.61%
Unlock

Based on analysts' sales estimates for 2025, the Rentokil Initial stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.23 20.07%
2025
2.17 2.50%
Unlock
2026
2.11 3.17%
Unlock
2027
2.02 3.93%
Unlock
2028
1.86 8.09%
Unlock

P/S ratio

Current 1.65 25.33%
2025
1.60 2.53%
Unlock
2026
1.55 3.17%
Unlock
2027
1.49 3.93%
Unlock
2028
1.37 8.09%
Unlock

Current Rentokil Initial Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Deutsche
Locked
Locked
Locked Mar 07 2025
JP Morgan Cazenove
Locked
Locked
Locked Jan 14 2025
Deutsche
Locked
Locked
Locked Sep 12 2024
Analyst Rating Date
Locked
Deutsche:
Locked
Locked
Mar 07 2025
Locked
JP Morgan Cazenove:
Locked
Locked
Jan 14 2025
Locked
Deutsche:
Locked
Locked
Sep 12 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today